SCHEMBL28019652

SCHEMBL28019652

CN(C(=O)N1CCCCC1)C1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 1/20 0.44
FAAH O00519 1/20 0.42
PHGDH O43175 1/20 0.42
MGLL Q99685 1/20 0.42
ALDH1A1 P00352 3/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 1/20 0.41
HSD11B1 P28845 1/20 0.40
HSD11B2 P80365 1/20 0.40
ATM Q13315 1/20 0.40
KMT2A Q03164 1/20 0.40
JAK1 P23458 1/20 0.40
TSHR P16473 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24518383 1.00 LIPE (0.44) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL15551380 1.00 LIPE (0.44) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL31097151 0.94 HPGD (0.43) LIPEALDH1A1HPGDHTTHSD11B1
SCHEMBL1561215 0.87 LMNA (0.49) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL28960167 0.85 CA2 (0.44) LIPEHPGDHSD11B1HSD11B2KMT2A
SCHEMBL30967383 0.85 CA2 (0.44) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL4375383 0.85 MAPT (0.50) LIPEALDH1A1PKMHTTKMT2A
SCHEMBL30967349 0.83 CHRNB2 (0.44) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL19001142 0.83 LIPE (0.39) LIPEFAAHPHGDHMGLLALDH1A1
SCHEMBL30967375 0.81 CHRNB2 (0.46) LIPEALDH1A1PKMHSD11B1HSD11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104666299-A 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof GALDERMA RES & DEV 2015-06-03 CN claimed
CN-104666299-A 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof GALDERMA RES & DEV 2015-06-03 CN disclosed